LFCR (Lifecore Biomedical) Long-Term Debt : $119.0 Mil (As of Nov. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Lifecore Biomedical Long-Term Debt?

Lifecore Biomedical's Long-Term Debt for the quarter that ended in Nov. 2024 was $119.0 Mil.

Lifecore Biomedical's quarterly Long-Term Debt increased from May. 2024 ($120.5 Mil) to Aug. 2024 ($127.2 Mil) but then declined from Aug. 2024 ($127.2 Mil) to Nov. 2024 ($119.0 Mil).

Lifecore Biomedical's annual Long-Term Debt increased from May. 2022 ($97.6 Mil) to May. 2023 ($101.1 Mil) and increased from May. 2023 ($101.1 Mil) to May. 2024 ($120.5 Mil).

Lifecore Biomedical Long-Term Debt Historical Data

The historical data trend for Lifecore Biomedical's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecore Biomedical Long-Term Debt Chart

Lifecore Biomedical Annual Data

Trend

May15

May16

May17

May18

May19

May20

May21

May22

May23

May24

Long-Term Debt

Get a 7-Day Free Trial

101.36

164.90

97.58

101.07

120.51

Lifecore Biomedical Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Long-Term Debt	Get a 7-Day Free Trial															108.96	116.25	120.51	127.15	119.03

Lifecore Biomedical (NAS:LFCR) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Lifecore Biomedical Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifecore Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lifecore Biomedical Inc (NAS:LFCR) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

LDE:Germany

Address

3515 Lyman Boulevard, Chaska, MN, USA, 55318

Website

https://www.lifecore.com

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

Executives

Wynnefield Partners Small Cap Value Lp I	10 percent owner	450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Christopher S Kiper	director	12121 WILSHIRE BLVD, SUITE 1240, LOS ANGELES CA 90025
Raymond T. White	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, Llc	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Holdings, Llc	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. Ii	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. I	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Asset Management, Llc	director	12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Nathaniel Calloway	director	C/O ANEBULO PHARMACEUTICALS, INC., 1415 RANCH ROAD 620 SOUTH, SUITE 201, LAKEWAY TX 78734
Raymond H Diradoorian	director	C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Joshua Schechter	director	C/O THE PANTRY, INC., 305 GREGSON DRIVE, CARY NC 27511
Patrick D Walsh	director	14282 FRANKLIN AVE., TUSTIN CA 92780
John D Morberg	officer: Chief Financial Officer	C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Albert D. Bolles	director	CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
James G Hall	officer: Executive Vice President	3515 LYMAN BLVD., CHASKA MN 55318